2 ML sugammadex 100 MG/ML Injection

RxCUI
1726992
RxNorm name
2 ML sugammadex 100 MG/ML Injection
Display name
Sugammadex (Injectable)
Full name
2 ML sugammadex 100 MG/ML Injection
Term type
SCD
Status
Active
Strength
100 mg/ml
Dose form
Injection 2 ml
Route
Injectable
Updated
2026-11-06 11:16:11

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
012016
Active start
012016
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
sugammadex sodium100 MG / 1 MLsugammadexsugammadex

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Injection1649574

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
sugammadex1726988

Source Vocabulary Codes#

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
0264-8200-100264-8200Sugammadex SugammadexB. Braun Medical Inc.ANDA214279
0781-3468-950781-3468Sugammadex sugammadexSandoz IncANDA214311
16729-726-0316729-726sugammadex sugammadexAccord Healthcare Inc.ANDA214306
25021-619-0225021-619Sugammadex Sugammadex SodiumSagent PharmaceuticalsANDA215575
31722-254-1031722-254Sugammadex SugammadexCamber Pharmaceuticals, Inc.ANDA214337
42677-311-1042677-311Sugammadex SugammadexShandong New Time Pharmaceutical Co., Ltd.ANDA215701
43598-924-2643598-924Sugammadex SugammadexDr. Reddy's Laboratories Inc.ANDA214236
55579-892-1055579-892sugammadex SUGAMMADEX SODIUMSolupharm Pharmazeutische Erzeugnisse GmbHANDA215260
62756-079-0262756-079sugammadex sugammadexSun Pharmaceutical Industries, Inc.ANDA214319
67457-969-0267457-969Sugammadex SugammadexMylan Institutional LLCANDA213915
68083-441-1068083-441sugammadex sugammadexGland Pharma LimitedANDA214364
68462-695-2068462-695sugammadex sugammadexGLENMARK PHARMACEUTICALS INC., USAANDA214364
70069-892-1070069-892sugammadex sugammadexSomerset Therapeutics, LLCANDA215260
70710-1650-670710-1650Sugammadex SugammadexZydus Pharmaceuticals USA Inc.ANDA214290
70748-370-0270748-370Sugammadex SugammadexLupin Pharmaceuticals, Inc.ANDA214338
70771-1856-670771-1856Sugammadex SugammadexZydus Lifesciences LimitedANDA214290
71872-7382-171872-7382sugammadex sugammadexMedical Purchasing Solutions, LLCANDA215260
72205-478-0272205-478Sugammadex SugammadexNovadoz Pharmaceuticals LLCANDA214368
72266-268-1072266-268sugammadex sugammadexFosun Pharma USA Inc.ANDA214364

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
ANDA2142790264-8200Sugammadex SugammadexANDAB. Braun Medical Inc.
ANDA2143110781-3468Sugammadex sugammadexANDASandoz Inc
ANDA21430616729-726sugammadex sugammadexANDAAccord Healthcare Inc.
ANDA21557525021-619Sugammadex Sugammadex SodiumANDASagent Pharmaceuticals
ANDA21433731722-254Sugammadex SugammadexANDACamber Pharmaceuticals, Inc.
ANDA21570142677-311Sugammadex SugammadexANDAShandong New Time Pharmaceutical Co., Ltd.
ANDA21423643598-924Sugammadex SugammadexANDADr. Reddy's Laboratories Inc.
ANDA21526055579-892sugammadex SUGAMMADEX SODIUMANDASolupharm Pharmazeutische Erzeugnisse GmbH
ANDA21431962756-079sugammadex sugammadexANDASun Pharmaceutical Industries, Inc.
ANDA21391567457-969Sugammadex SugammadexANDAMylan Institutional LLC
ANDA21436468083-441sugammadex sugammadexANDAGland Pharma Limited
ANDA21429070710-1650Sugammadex SugammadexANDAZydus Pharmaceuticals USA Inc.
ANDA21433870748-370Sugammadex SugammadexANDALupin Pharmaceuticals, Inc.
ANDA21436872205-478Sugammadex SugammadexANDANovadoz Pharmaceuticals LLC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 37 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00264820001rxnav_ndcsyes
00264820010rxnav_ndcsyes
00781346872rxnav_ndcsyes
00781346895rxnav_ndcsyes
16729072603rxnav_ndcsyes
16729072630rxnav_ndcsyes
25021061902rxnav_ndcsyes
31722025410rxnav_ndcsyes
31722025431rxnav_ndcsyes
42677031101rxnav_ndcsyes
42677031110rxnav_ndcsyes
43598092411rxnav_ndcsyes
43598092426rxnav_ndcsyes
55579089201rxnav_ndcsyes
55579089210rxnav_ndcsyes
62756007901rxnav_ndcsyes
62756007902rxnav_ndcsyes
66794025602rxnav_ndcsyes
66794025641rxnav_ndcsyes
67457096900rxnav_ndcsyes
67457096902rxnav_ndcsyes
68083044110rxnav_ndcsyes
68462069502rxnav_ndcsyes
68462069520rxnav_ndcsyes
70069089201rxnav_ndcsyes
70069089210rxnav_ndcsyes
70710165001rxnav_ndcsyes
70710165006rxnav_ndcsyes
70748037001rxnav_ndcsyes
70748037002rxnav_ndcsyes
70771185601rxnav_ndcsyes
70771185606rxnav_ndcsyes
71872738201rxnav_ndcsyes
72205047801rxnav_ndcsyes
72205047802rxnav_ndcsyes
72266026801rxnav_ndcsyes
72266026810rxnav_ndcsyes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 23 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SugammadexSUGAMMADEX SODIUMMullan Pharmaceutical Inc.5373abf1-c6ef-4295-9b2e-b07964b2fe372026-11-02Warnings, Adverse reactionsExact identifier
rxcui: 1726992
sugammadexSUGAMMADEXMedical Purchasing Solutions, LLC5b14e457-5ea1-3fe2-e063-6294a90aff6f2026-09-09Warnings, Adverse reactionsExact identifier
ndc (package): 71872-7382-1
ndc (product): 71872-7382
ndc11 (package): 71872738201
rxcui: 1726992
sugammadexSUGAMMADEX SODIUMSolupharm Pharmazeutische Erzeugnisse GmbHf92c4e53-13d1-46f2-acf8-6730c3cfac692026-08-20Warnings, Adverse reactionsExact identifier
ndc (package): 55579-892-10
ndc (product): 55579-892
ndc11 (package): 55579089210
ndc11 (package): 55579089201
rxcui: 1726992
sugammadexSUGAMMADEXAccord Healthcare Inc.57bf9b96-0550-b8e4-e063-6294a90a317b2026-08-05Warnings, Adverse reactionsExact identifier
ndc (package): 16729-726-03
ndc (product): 16729-726
ndc11 (package): 16729072603
rxcui: 1726992
sugammadexSUGAMMADEXSomerset Therapeutics, LLC70c00636-d4ba-4939-802c-9d5a92435c932026-08-03Warnings, Adverse reactionsExact identifier
ndc (package): 70069-892-10
ndc (product): 70069-892
ndc11 (package): 70069089201
ndc11 (package): 70069089210
rxcui: 1726992
SugammadexSUGAMMADEXLupin Pharmaceuticals, Inc.9f2e66d7-a5d2-4593-bb30-6d4a418381aa2026-07-31Warnings, Adverse reactionsExact identifier
ndc (package): 70748-370-02
ndc (product): 70748-370
ndc11 (package): 70748037002
ndc11 (package): 70748037001
rxcui: 1726992
sugammadexSUGAMMADEXGland Pharma Limitedc61ee55a-e61b-4d3c-9ebc-cbf57290e36c2026-07-28Warnings, Adverse reactionsExact identifier
ndc (package): 68083-441-10
ndc (product): 68083-441
ndc11 (package): 68083044110
rxcui: 1726992
SugammadexSUGAMMADEXB. Braun Medical Inc.d9d4467c-97ae-462a-9722-cc8d62db3e832026-07-28Warnings, Adverse reactionsExact identifier
ndc (package): 0264-8200-10
ndc (product): 0264-8200
ndc11 (package): 00264820010
ndc11 (package): 00264820001
rxcui: 1726992
sugammadexSUGAMMADEXGLENMARK PHARMACEUTICALS INC., USAe7897fc1-4553-460c-a29b-0bc91cd9ca102026-07-28Warnings, Adverse reactionsExact identifier
ndc (package): 68462-695-20
ndc (product): 68462-695
ndc11 (package): 68462069520
ndc11 (package): 68462069502
rxcui: 1726992
SugammadexSUGAMMADEXNovadoz Pharmaceuticals LLCab41ea1c-266f-421c-8fc4-6e7ff518a75d2026-07-09Warnings, Adverse reactionsExact identifier
ndc (package): 72205-478-02
ndc (product): 72205-478
ndc11 (package): 72205047801
ndc11 (package): 72205047802
rxcui: 1726992
sugammadexSUGAMMADEXSun Pharmaceutical Industries, Inc.55b2eb4e-4d77-c555-e063-6294a90abf9e2026-07-03Warnings, Adverse reactionsExact identifier
ndc (package): 62756-079-02
ndc (product): 62756-079
ndc11 (package): 62756007901
ndc11 (package): 62756007902
rxcui: 1726992
SugammadexSUGAMMADEXZydus Pharmaceuticals USA Inc.21028965-598b-4cfa-a614-5c28ed40306a2026-07-02Warnings, Adverse reactionsExact identifier
ndc (package): 70710-1650-6
ndc (product): 70710-1650
ndc11 (package): 70710165006
ndc11 (package): 70710165001
rxcui: 1726992
SugammadexSUGAMMADEXZydus Lifesciences Limitedb1ec2b5e-a571-4511-ab44-d4193441330a2026-07-02Exact identifier
ndc (package): 70771-1856-6
ndc (product): 70771-1856
ndc11 (package): 70771185606
ndc11 (package): 70771185601
rxcui: 1726992
SugammadexSUGAMMADEX SODIUMSagent Pharmaceuticals5b25f16e-726a-4464-88da-b188c2f4e0382026-06-16Warnings, Adverse reactionsExact identifier
ndc (package): 25021-619-02
ndc (product): 25021-619
ndc11 (package): 25021061902
rxcui: 1726992
SugammadexSUGAMMADEXCamber Pharmaceuticals, Inc.9adda802-fab2-40c1-9c2f-358debdfb2492026-05-30Warnings, Adverse reactionsExact identifier
ndc (package): 31722-254-10
ndc (product): 31722-254
ndc11 (package): 31722025410
rxcui: 1726992
sugammadexSUGAMMADEXFosun Pharma USA Inc.4f1c7cf8-3db7-3f92-e063-6394a90aece92026-04-03Warnings, Adverse reactionsExact identifier
ndc (package): 72266-268-10
ndc (product): 72266-268
ndc11 (package): 72266026810
ndc11 (package): 72266026801
rxcui: 1726992
BRIDIONSUGAMMADEXMerck Sharp & Dohme LLC5171d883-fe8f-482c-97ab-40b00975b64a2026-03-13Warnings, Adverse reactionsExact identifier
rxcui: 1726992
SugammadexSUGAMMADEXDr. Reddy's Laboratories Inc.4f90c37e-3505-0968-38fd-fc7e4dd66e822026-02-18Warnings, Adverse reactionsExact identifier
ndc (package): 43598-924-26
ndc (product): 43598-924
ndc11 (package): 43598092411
ndc11 (package): 43598092426
rxcui: 1726992
SugammadexSUGAMMADEXMylan Institutional LLCeb84def8-933b-4eba-b81f-30d40b1e3d8d2026-02-04Warnings, Adverse reactionsExact identifier
ndc (package): 67457-969-02
ndc (product): 67457-969
ndc11 (package): 67457096902
ndc11 (package): 67457096900
rxcui: 1726992
SugammadexSUGAMMADEXSandoz Inc6cf43d88-d410-439e-a2e5-e31086f14fc22026-01-31Warnings, Adverse reactionsExact identifier
ndc (package): 0781-3468-95
ndc (product): 0781-3468
ndc11 (package): 00781346895
ndc11 (package): 00781346872
rxcui: 1726992

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
5171d883-fe8f-482c-97ab-40b00975b64asugammadex 200 MG in 2 ML Injection [PSN] · 2 ML sugammadex 100 MG/ML Injection [SCD] · sugammadex 200 MG per 2 ML Injection [SY]326These highlights do not include all the information needed to use BRIDION safely and effectively. See full prescribing information for BRIDION. BRIDION ® (sugammadex) Injection, for intravenous use Initial U.S. Approval: 201520260313
37276948-ff0f-e0ab-e063-6394a90a0973sugammadex 200 MG in 2 ML Injection [PSN] · 2 ML sugammadex 100 MG/ML Injection [SCD] · sugammadex 200 MG per 2 ML Injection [SY]33These highlights do not include all the information needed to use BRIDION safely and effectively. See full prescribing information for BRIDION. BRIDION ® (sugammadex) Injection, for intravenous use Initial U.S. Approval: 201520251218
9e3eb206-5c35-2c93-e053-2a95a90a9df0sugammadex 200 MG in 2 ML Injection [PSN] · 2 ML sugammadex 100 MG/ML Injection [SCD] · sugammadex 200 MG per 2 ML Injection [SY]32These highlights do not include all the information needed to use BRIDION safely and effectively. See full prescribing information for BRIDION. BRIDION ® (sugammadex) Injection, for intravenous use Initial U.S. Approval: 201520230510

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
5b14e457-5ea1-3fe2-e063-6294a90aff6fThese highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval:2015Medical Purchasing Solutions, LLC20260909
f92c4e53-13d1-46f2-acf8-6730c3cfac69These highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval:2015Solupharm Pharmazeutische Erzeugnisse GmbH20260820
57bf9b96-0550-b8e4-e063-6294a90a317bThese highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval: 2015 Additional pediatric use information is approved for Merck Sharp & Dohme LLC’s BRIDION® (sugammadex) injection. However, due to Merck Sharp & Dohme LLC’s marketing exclusivity rights, this drug product is not labeled with that information.Accord Healthcare Inc.20260805
70c00636-d4ba-4939-802c-9d5a92435c93These highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval:2015Somerset Therapeutics, LLC | Solupharm Pharmazeutische Erzeugnisse GmbH20260803
9f2e66d7-a5d2-4593-bb30-6d4a418381aaThese highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX Injection, for intravenous use Initial U.S. Approval: 2015Lupin Pharmaceuticals, Inc. | LUPIN LIMITED20260731
c61ee55a-e61b-4d3c-9ebc-cbf57290e36cThese highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval: 2015Gland Pharma Limited20260728
d9d4467c-97ae-462a-9722-cc8d62db3e83These highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval: 2015B. Braun Medical Inc.20260728
e7897fc1-4553-460c-a29b-0bc91cd9ca10These highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval: 2015GLENMARK PHARMACEUTICALS INC., USA | Gland Pharma Limited20260728
ab41ea1c-266f-421c-8fc4-6e7ff518a75dThese highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval: 2015Novadoz Pharmaceuticals LLC | MSN LABORATORIES PRIVATE LIMITED20260728
70c00636-d4ba-4939-802c-9d5a92435c93These highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval:2015Somerset Therapeutics, LLC | Solupharm Pharmazeutische Erzeugnisse GmbH20260711
ab41ea1c-266f-421c-8fc4-6e7ff518a75dThese highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval: 2015Novadoz Pharmaceuticals LLC | MSN LABORATORIES PRIVATE LIMITED20260709
55b2eb4e-4d77-c555-e063-6294a90abf9eThese highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval: 2015Sun Pharmaceutical Industries, Inc. | Wasserburger Arzneimittelwerk GmbH20260703
21028965-598b-4cfa-a614-5c28ed40306aThese highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION SUGAMMADEX injection, for intravenous use Initial U.S. Approval: 2015Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited20260702
b1ec2b5e-a571-4511-ab44-d4193441330aSUGAMMADEX injection, for intravenous useZydus Lifesciences Limited20260702
5b25f16e-726a-4464-88da-b188c2f4e038These highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval: 2015Sagent Pharmaceuticals20260616
9adda802-fab2-40c1-9c2f-358debdfb249These highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval: 2015Camber Pharmaceuticals, Inc. | Aspiro Pharma Limited20260530
4f1c7cf8-3db7-3f92-e063-6394a90aece9These highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval: 2015Fosun Pharma USA Inc.20260403
4f90c37e-3505-0968-38fd-fc7e4dd66e82These highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval: 2015 .Dr. Reddy's Laboratories Inc. | Dr. Reddy's Laboratories Limited-FTO920260218
eb84def8-933b-4eba-b81f-30d40b1e3d8dThese highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION . SUGAMMADEX injection, for intravenous use Initial U.S. Approval: 2015Mylan Institutional LLC20260204
6cf43d88-d410-439e-a2e5-e31086f14fc2These highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval: 2015Sandoz Inc20260131
056afa51-c887-ecdf-e063-6394a90a49ffSUGAMMADEX INJECTION HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX INJECTION, for intravenous use Initial U.S. Approval: 2015Piramal Critical Care Inc.20250923
56400560-a2df-4126-b424-9e4b91e53a8bThese highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval: 2015Shandong New Time Pharmaceutical Co., Ltd.20250324

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCV03ABAntidotesATC1-4sugammadex
FDASPLD047408gamma-CyclodextrinsCHEMhas_chemical_structuresugammadex
MEDRTD000077122SugammadexCHEMhas_ingredientsugammadex

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH100 MG/ML
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESQUANTITY2 ML
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESANDAANDA213915
CODESANDAANDA214236
CODESANDAANDA214279
CODESANDAANDA214290
CODESANDAANDA214306
CODESANDAANDA214311
CODESANDAANDA214319
CODESANDAANDA214337
CODESANDAANDA214338
CODESANDAANDA214364
CODESANDAANDA214368
CODESANDAANDA215260
CODESANDAANDA215575
CODESANDAANDA215701
CODESVUID4035290
NAMESPrescribable Synonymsugammadex 200 MG in 2 ML Injection
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceVeterans Health Administration National Drug File